» Articles » PMID: 7925446

Peptide Substrate Specificity and Properties of the Zinc-endopeptidase Activity of Botulinum Type B Neurotoxin

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1994 Oct 1
PMID 7925446
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium botulinum type B neurotoxin has been shown to be a zinc endopeptidase specific for vesicle-associated membrane protein (VAMP). A synthetic peptide of human/rat VAMP-2 [VAMP-2-(60-94)] is cleaved by the neurotoxin with the same specificity as that demonstrated for the membrane-associated protein (at the Gln76-Phe77 bond) and has been used to study the properties of the endopeptidase activity of the neurotoxin. Cleavage of the VAMP-2 peptide was demonstrated by both botulinum type B neurotoxin (Km = 3.3 x 10(-4) M) and by its purified light subunit (Km = 3.5 x 10(-4) M). The endopeptidase displayed a pH optimum of 7.0-7.5 and was inhibited by greater than 0.2 M NaCl and greater than 0.05 M sodium phosphate. Neurotoxin which had been inactivated by dialysis against EDTA could be re-activated by incubation with various divalent cations, notably Zn2+ and Cu2+. The substrate specificity of botulinum type B neurotoxin was studied using various analogues of VAMP-2 (60-94). The neurotoxin cleaved selectively to the N-terminal side of phenylalanine and tyrosine; no activity was observed with either leucine, valine or alanine in the P'1 position. The properties of the P1 amino acid were less critical; the neurotoxin cleaving the C-terminus of glutamine, asparagine and alanine. A substrate analogue with valine in the P1 position corresponding to the sequence of rat VAMP-1 was not cleaved. The rate of cleavage of a substrate analogue representing the sequence of human VAMP-1, however, was more than twofold that of the VAMP-2 peptide. The properties and substrate specificity of botulinum type B neurotoxin suggest that the toxin represents a novel class of endopeptidase which requires a specific peptide substrate conformation for the expression of proteolytic activity.

Citing Articles

Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments.

von Berg L, Stern D, Weisemann J, Rummel A, Dorner M, Dorner B Toxins (Basel). 2019; 11(10).

PMID: 31614566 PMC: 6832249. DOI: 10.3390/toxins11100588.


Sensitive detection of type G botulinum neurotoxin through Endopep-MS peptide substrate optimization.

Wang D, Baudys J, Hoyt K, Barr J, Kalb S Anal Bioanal Chem. 2019; 411(21):5489-5497.

PMID: 31172236 PMC: 6684539. DOI: 10.1007/s00216-019-01926-8.


Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity.

Fonfria E, Elliott M, Beard M, Chaddock J, Krupp J Toxins (Basel). 2018; 10(7).

PMID: 29973505 PMC: 6071219. DOI: 10.3390/toxins10070278.


Nanopore sensing of botulinum toxin type B by discriminating an enzymatically cleaved Peptide from a synaptic protein synaptobrevin 2 derivative.

Wang Y, Montana V, Grubisic V, Stout Jr R, Parpura V, Gu L ACS Appl Mater Interfaces. 2014; 7(1):184-92.

PMID: 25511125 PMC: 4296922. DOI: 10.1021/am5056596.


Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin.

Mizanur R, Stafford R, Ahmed S PLoS One. 2014; 9(4):e95188.

PMID: 24769566 PMC: 4000213. DOI: 10.1371/journal.pone.0095188.